Showing results (41-50 of 101) with videos related to

Sort By:
Pageof 11
Antimicrobial Agents and Chemotherapy|January 20, 2021
The Role of New Posaconazole Formulations in the Treatment of Candida albicans Infections: Data from an In Vitro Pharmacokinetic-Pharmacodynamic ModelMaria-Ioanna Beredaki, Maiken Cavling Arendrup, David Andes, et al.
Antimicrobial Agents and Chemotherapy|May 9, 2018
Isavuconazole Concentration in Real-World Practice: Consistency with Results from Clinical TrialsDavid Andes, Laura Kovanda, A Desai, et al.
The Journal of Antimicrobial Chemotherapy|November 27, 2018
Variability and exposure-response relationships of isavuconazole plasma concentrations in the Phase 3 SECURE trial of patients with invasive mould diseasesThomas Kaindl, David Andes, Marc Engelhardt, et al.
Diagnostic Microbiology and Infectious Disease|December 8, 2009
Infections after the use of alemtuzumab in solid organ transplant recipients: a comparative studyNasia Safdar, Jeannina Smith, Valerie Knasinski, et al.
The Journal of Arthroplasty|July 12, 2008
Premixed antibiotic bone cement: an in vitro comparison of antimicrobial efficacyMatthew W Squire, Brian J Ludwig, Jonathan R Thompson, et al.
Advanced Materials (Deerfield Beach, Fla.)|January 22, 2021
A Dual-Responsive Antibiotic-Loaded Nanoparticle Specifically Binds Pathogens and Overcomes Antimicrobial-Resistant InfectionsMingzhou Ye, Yi Zhao, Yuyuan Wang, et al.
Mbio|October 13, 2016
Commensal Protection of Staphylococcus aureus against Antimicrobials by Candida albicans Biofilm MatrixEric F Kong, Christina Tsui, Sona Kucharíková, et al.
Infection and Immunity|July 26, 2005
Aspergillus cyclooxygenase-like enzymes are associated with prostaglandin production and virulenceDimitrios I Tsitsigiannis, Jin-Woo Bok, David Andes, et al.
Antimicrobial Agents and Chemotherapy|May 4, 2011
Protein binding: do we ever learn?Markus A Zeitlinger, Hartmut Derendorf, Johan W Mouton, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 21, 2024
Piperacillin/Tazobactam Susceptibility Test Interpretive Criteria for Enterobacterales: Recommendations From the United States Committee on Antimicrobial Susceptibility TestingThomas P Lodise, Sujata M Bhavnani, Paul G Ambrose, et al.
Pageof 11